BMRs possess anti-tumor mechanisms reported in NMRs that we have discussed above, such as over-secretion of HMM-HA, which here has been associated with an increased protection against ROS-induced damage [26,45]. The gene discussed is EXOC3L2; the disease is neoplasm.